Fatal Hepatic Decompensation in a Patient with Hepatitis B Cirrhosis Following Famciclovir Withdrawal
Hepatitis B virus (HBV) infection is a major cause of chronic liver disease worldwide. Famciclovir is a nucleoside analogue with potent antiviral activity that appears promising in the management of patients with HBV infection. No data exist regarding the safety of nucleoside analogue withdrawal in...
Saved in:
Main Authors: | Robert P Myers, Rabindra Chaudhary, Kevin Fonseca, Samuel S Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2000-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/2000/142782 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hepatic myelopathy in chronic hepatitis B-related decompensated cirrhosis: A case report and literature review
by: Longqi Jiang, et al.
Published: (2025-02-01) -
Improving Survival in Decompensated Cirrhosis
by: Amar Nath Mukerji, et al.
Published: (2012-01-01) -
Safety and Efficacy of Hepatitis B Vaccination in Cirrhosis of Liver
by: D. Ajith Roni, et al.
Published: (2013-01-01) -
Acute Coinfection with Hepatitis B and Hepatitis C Viruses
by: Brian M Yan, et al.
Published: (2005-01-01) -
Inflammatory lipid biomarkers and transplant-free mortality risk in hepatitis B-related cirrhosis and hepatic encephalopathy
by: Ke Shi, et al.
Published: (2025-01-01)